Annai Jindi Ji (安乃近滴剂)安乃近滴剂
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 通化东圣药业股份有限公司Chinese legal name: 通化东圣药业股份有限公司
主要成分Active Ingredients
- 安乃近Annai Jin
- 其化学名为Qihua Xueming Wei
- 二甲基--苯基
药物知识说明
安乃近是一种在国家药监局注册认定的药品。该药品含有其化学名为、安乃近-6871c0e7等成分。
该药品关联的活性成分包括：其化学名为、安乃近Annai Jin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：通化东圣药业股份有限公司Chinese legal name: 通化东圣药业股份有限公司。
您可以探索含有相同成分的其他药品：其化学名为-9702a577成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 安乃近滴剂) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 安乃近Annai Jin.
Manufacturers recorded for this product: 通化东圣药业股份有限公司Chinese legal name: 通化东圣药业股份有限公司.
Explore other medicines containing the same ingredient: 其化学名为 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 安乃近滴剂Recorded Chinese name: 安乃近滴剂
- 规格Specification: 1ml:0.2g1 mL:0.2 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 通化东圣药业股份有限公司Chinese legal name: 通化东圣药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H22020471
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H22020471
Manufacturer
Chinese legal name: 通化东圣药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H22020471
生产企业
通化东圣药业股份有限公司(国产)
适应症
用于小儿高热解热。
用法用量
口服 小儿按体重一次10～20mg/kg，一日2～3次。
不良反应
本品对胃肠道的刺激虽较小，但可引起以下各种不良反应：
1.血液方面，可引起粒细胞缺乏症，发生率约1.1%，急性起病，重者有致命危险，亦可引起自身免疫性溶血性贫血、血小板减少性紫癜、再生障碍性贫血等；
2.皮肤方面，可引起荨麻疹、渗出性红斑等过敏性表现，严重者可发生剥脱性皮炎、表皮松解症等；
3.个别病例可发生过敏性休克，甚至导致死亡。
禁忌
对本品或氨基比林有过敏史者禁用。
注意事项
1.本品与阿司匹林有交叉过敏反应。
2.不宜长期应用。
3.本品一般不作首选用药，仅在急性高热、病情急重，又无其他有效解热药可用的情况下用于紧急退热。
4.本品用药超过1周时应定期检查血象，一旦发生粒细胞减少，应立即停药。
5.体弱者慎用。
贮藏
密封，置阴凉处。
规格
1ml:0.2g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.